A groundbreaking new review published in the prestigious journal EXO – Beyond the Cell – explores how cutting-edge advances in synthetic biology, artificial intelligence, and spatial omics are poised to revolutionize the longstanding challenge of ligand-receptor discovery. For decades, unraveling the complex communication networks mediated by secreted signaling proteins has been hampered by the difficulty of identifying the receptors that detect these ligands. This “orphan receptor” problem has constrained understanding of fundamental biological processes and limited drug development efforts. The review authored by Harvard Medical School researchers Myeonghoon Han and Norbert Perrimon outlines a visionary roadmap that could transform the field from slow, incremental one-by-one searches into dynamic, scalable network-level mapping.
Cellular communication is orchestrated by secreted ligands binding to cell surface receptors, thereby triggering cascades regulating immunity, development, metabolism, and tissue repair. However, many secreted molecules remain orphans — their corresponding receptors remain unknown. Traditional biochemical methods, such as affinity purification coupled with mass spectrometry (AP-MS), have facilitated direct detection of ligand-receptor interactions. Despite their utility, these approaches are limited by their inability to reliably capture weak or ephemeral extracellular bindings that characterize many physiologically relevant interactions. Consequently, identifying pairs through these methods has often been painstakingly slow and incomplete.
Genetic screening platforms have emerged as another major pillar in ligand-receptor identification. RNA interference (RNAi) and CRISPR-based screens can achieve high-throughput interrogation of gene function, enabling physiological relevance and scalability. Yet their dependence on detectable cellular phenotypes poses a critical bottleneck when studying orphan ligands; phenotypic readouts necessary for these screens are frequently unknown or subtle in these contexts. Without clear phenotypic changes, genetic screens struggle to uncover ligand-receptor pairs on a broad, unbiased basis, creating another hurdle for comprehensive deorphanization.
The computational landscape has been transformed recently with the advent of AI-driven structural prediction tools such as AlphaFold-Multimer and AlphaFold3. These models predict protein-protein interactions at unprecedented scale and accuracy, expanding the possibilities for in silico ligand-receptor mapping. Nonetheless, current algorithms do not fully account for critical biological nuances including protein processing, cleavage, and post-translational modifications, all of which profoundly influence real-world receptor binding dynamics. Hence, purely computational predictions remain insufficient without complementary biochemical or cellular validation.
Rather than endorsing any singular approach, this new review emphasizes integration of multiple cutting-edge methodologies as the future of ligand-receptor discovery. A prominent vision involves multiplexed screening platforms capable of concurrently testing entire ligand and receptor libraries. Such systems would enable a paradigm shift from one-by-one pairwise identification toward holistic network-level elucidation, capturing the intricate, multidimensional signaling landscapes that govern physiological processes. This multiplexing capability promises to accelerate discovery by orders of magnitude.
The review also sheds light on innovative biochemical advances specifically designed to stabilize fleeting extracellular interactions. Techniques such as AVEXIS (Avidity-based Extracellular Interaction Screen) and covalent capture systems—most notably the SpyTag/SpyCatcher technology—offer approaches to “trap” transient ligand-receptor contacts that were previously too weak or short-lived for conventional detection. By chemically or genetically locking these interactions for downstream analysis, these methods significantly expand the detectable interactome and deepen understanding of signaling complexity.
Perhaps most transformative is the role synthetic biology could play in overcoming traditional barriers. Systems like synNotch, JUPITER, and PAGER record physical contact events irrespective of binding affinity. These tools convert brief ligand-receptor encounters into stable fluorescent or genetic outputs, effectively immortalizing transient interactions in a way that cellular internalization or receptor endocytosis cannot erase. This capability marks a fundamental breakthrough for mapping elusive receptor engagement in living systems, enabling functional insights inaccessible to prior methods.
Complementing these efforts, integration with single-cell and spatial transcriptomics technologies is crucial for contextualizing ligand-receptor interactions within physiological tissues. High-resolution tools such as CellPhoneDB and FlyPhoneDB2 enable inference of intercellular communication patterns by cross-referencing ligand expression and receptor profiles at the single-cell level. Meanwhile, spatial transcriptomics platforms like MERFISH and Slide-seq preserve native tissue architecture, revealing how signaling networks organize and function in situ. This spatially informed perspective is vital for decoding complex cellular crosstalk underlying health and disease.
The authors underscore that future ligand-receptor deorphanization efforts will hinge upon a synergistic melding of biochemical stabilization techniques, multiplexed high-throughput screens, AI-based interaction prediction, synthetic biology sensors, and spatial multi-omics. By leveraging the complementary strengths of these modalities, researchers can uncover comprehensive signaling networks that dictate organismal physiology across tissues and organs. This integrated roadmap sets the stage for unprecedented discovery in receptor biology, unlocking new avenues for therapeutic intervention and fundamental insight.
Such convergence of technologies not only enhances mechanistic understanding but holds tremendous promise for accelerating drug discovery pipelines. Identifying orphan ligand-receptor pairs implicated in pathophysiology can pinpoint novel targets for modulation, enabling precision medicine strategies targeting intercellular communication axes. Furthermore, scalable network mapping allows systematic interrogation of signaling rewiring in diseases such as cancer, neurodegeneration, and immune disorders, fostering translational breakthroughs.
Ultimately, the review heralds a new era in cell signaling research—one defined by expansive, systems-level discovery instead of painstaking one-at-a-time validation. Harnessing AI, synthetic biology, and spatial omics in concert will empower scientists to decode the language of cellular communication with unprecedented breadth and depth. As these frontiers converge, previously hidden signaling networks will emerge from obscurity, driving a renaissance in molecular biology and therapeutic innovation.
This visionary synthesis from Han and Perrimon redefines the scientific quest to deorphanize secreted ligands and their receptors. The roadmap they lay out promises to dramatically accelerate our capacity to map and manipulate intercellular signaling landscapes, with broad ramifications for understanding health, disease, and development. As these technologies mature and integrate, the field stands poised on the verge of transformative discovery and application, unlocking the secrets of the cellular “dark matter” that orchestrates life itself.
Subject of Research: Not applicable
Article Title: Approaches to deorphanize secretome: Classical, computational, and next generation strategies to reveal ligand-receptor networks
News Publication Date: 11-May-2026
Web References: http://dx.doi.org/10.70401/EXO.2026.0008
References: See original review article for comprehensive literature citations
Keywords: ligand-receptor discovery, deorphanization, synthetic biology, spatial omics, AI prediction, multiplex screening, secretome, cell signaling, biochemical stabilization
